Antimicrobial resistance (AMR) has become a global medical priority that needs urgent
resolution. Pseudomonas aeruginosa is a versatile, adaptable bacterial species with …

Antibiotics are powerful drugs used in the treatment of bacterial infections. The inappropriate
use of these medicines has driven the dissemination of antibiotic resistance (AR) in most …

Pseudomonas aeruginosa is a member of Pseudomonatoda (synonym Proteobacteria)
phylum, belonging to the group of non-fermenting Gram-negative bacteria (NFGNB)(Oren …

Background Pseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in many
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …

Objectives Pseudomonas aeruginosa is a leading cause of community-and hospital-
acquired infections. Successful treatment is hampered by its remarkable ability to rapidly …

Scope Pseudomonas aeruginosa, a ubiquitous opportunistic pathogen considered one of
the paradigms of antimicrobial resistance, is among the main causes of hospital-acquired …

Antimicrobial resistance is one of the most serious public health issues facing humans since
the discovery of antimicrobial agents. The frequent, prolonged, and uncontrolled use of …

Pseudomonas aeruginosa is often resistant to multiple antibiotics and consequently has
joined the ranks of 'superbugs' due to its enormous capacity to engender resistance. It …

The emergence of antimicrobial drug resistance is of enormous public concern due to the
increased risk of delayed treatment of infections, the increased length of hospital stays, the …

Pseudomonas aeruginosa is a formidable pathogen in the infection arena. It is able to easily
adapt to the environment which it inhabits and can also colonize and invade the human host …